Purus Wealth Management LLC Acquires 94 Shares of Axon Enterprise, Inc $AXON

Purus Wealth Management LLC lifted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 4.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,142 shares of the biotechnology company’s stock after purchasing an additional 94 shares during the period. Purus Wealth Management LLC’s holdings in Axon Enterprise were worth $1,127,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. TCTC Holdings LLC boosted its position in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after purchasing an additional 24 shares in the last quarter. Fourth Dimension Wealth LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at about $30,000. Bartlett & CO. Wealth Management LLC boosted its position in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after purchasing an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC bought a new position in Axon Enterprise in the first quarter worth approximately $32,000. Finally, Alpine Bank Wealth Management bought a new position in Axon Enterprise in the first quarter worth approximately $40,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of several recent research reports. Barclays increased their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Northland Securities set a $800.00 price target on Axon Enterprise in a report on Tuesday, August 5th. JMP Securities increased their price target on Axon Enterprise from $725.00 to $825.00 and gave the stock a “market outperform” rating in a report on Tuesday, July 22nd. The Goldman Sachs Group increased their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a report on Wednesday, May 14th. Finally, UBS Group reissued a “neutral” rating and issued a $840.00 price objective (up from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $837.69.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $763.51 on Friday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The company has a market cap of $59.94 billion, a PE ratio of 188.52, a price-to-earnings-growth ratio of 27.93 and a beta of 1.36. The business has a 50 day moving average price of $773.34 and a 200-day moving average price of $673.33. Axon Enterprise, Inc has a 52 week low of $346.71 and a 52 week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.Axon Enterprise’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same period last year, the company posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In related news, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the sale, the president directly owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Hadi Partovi purchased 1,358 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The shares were acquired at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the acquisition, the director directly owned 237,938 shares of the company’s stock, valued at $176,074,120. This trade represents a 0.57% increase in their position. The disclosure for this purchase can be found here. Insiders sold a total of 43,790 shares of company stock valued at $33,654,451 in the last ninety days. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.